Teva Must Face Bulk Of Asthma Inhaler Antitrust Suit

By Bryan Koenig

A Massachusetts federal judge largely refused Tuesday to toss antitrust claims accusing Teva of a decadelong anticompetitive scheme to delay generic competition for its blockbuster QVAR asthma inhalers, finding it plausible that Teva paid off a would-be rival and forcibly switched doctors and patients to a new product.

 Memorandum attached | Read full article » | Save to favorites »